原始来源记录
重大EMA 意见
艾伯维：Boey（trenibotulinumtoxinE）治疗眉间纹获CHMP积极意见
CHMP通过积极意见，建议欧盟批准Boey（trenibotulinumtoxinE）用于成人中重度眉间纹。该意见覆盖30个欧洲经济区市场，依据两项关键3期试验显示起效最早8小时、持续2-3周。欧洲委员会预计将在未来数月作出决定。
关键事实
来源摘录
Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults News provided by AbbVie May 21, 2026, 16:10 ET Share this article Share to X Share this article Share to X Boey ® has received a positive opinion from the CHMP for 30 EU & EEA markets If approved, Boey ® has the potential to be the first and only botulinum neurotoxin serotype E that adult patients can try for the temporary improvement of Glabellar Lines Positive opinion is supported by data from two pivotal Phase 3 trials, which demonstrated rapid results as ea